Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
15.13 USD | -0.13% | -.--% | +12.83% |
May. 21 | Merrimack Pharmaceuticals, Inc.(NasdaqGM:MACK) dropped from S&P Global BMI Index | CI |
May. 21 | Merrimack Pharmaceuticals, Inc.(NasdaqGM:MACK) dropped from S&P TMI Index | CI |
Financials (USD)
Sales 2022 | - | Sales 2023 | - | Capitalization | 192M |
---|---|---|---|---|---|
Net income 2022 | -1M | Net income 2023 | -1M | EV / Sales 2022 | - |
Net cash position 2022 | 19.44M | Net cash position 2023 | 18.88M | EV / Sales 2023 | - |
P/E ratio 2022 |
-100
x | P/E ratio 2023 |
-162
x | Employees | 27 |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 98.81% |
1 day | -0.13% | ||
3 months | +2.72% | ||
6 months | +14.97% | ||
Current year | +12.83% |
Managers | Title | Age | Since |
---|---|---|---|
Ulrik Nielsen
FOU | Founder | 52 | 92-12-31 |
Gary Crocker
CEO | Chief Executive Officer | 72 | 03-12-31 |
Investor Relations Contact | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Gary Crocker
CEO | Chief Executive Officer | 72 | 03-12-31 |
Director/Board Member | 46 | 19-09-18 | |
Ulrik Nielsen
FOU | Founder | 52 | 92-12-31 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.50% | 4 M€ | -5.15% | - | |
0.00% | 32 M€ | +6.20% | - |
1st Jan change | Capi. | |
---|---|---|
+12.83% | 224M | |
+23.50% | 47.07B | |
+47.19% | 42.06B | |
-5.16% | 39.98B | |
+36.37% | 33.02B | |
-7.79% | 27.9B | |
+18.06% | 27.63B | |
+47.29% | 14.37B | |
+41.91% | 13.45B | |
-1.02% | 12.03B |
- Stock Market
- Equities
- MACK Stock